Back to mobile site

Ivax Diagnostics, Inc. (IVD) Narrows Q2 Loss

August 23, 2011 6:37 AM EDT
Ivax Diagnostics, Inc. (NYSE: IVD) reported Q2 EPS of ($0.03), $0.02 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $4.38 million versus the consensus estimate of $4.39 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings